Form 4: Concentra CEO Granted 225,000 Restricted Stock Units

Sentiment:

Insider Transaction Report


Concentra Group Holdings Parent, Inc. CEO William Keith Newton received a grant of 225,000 restricted common stock shares, vesting over four years.

Summary

  • William Keith Newton, Chief Executive Officer and Director of Concentra Group Holdings Parent, Inc. (CON), was granted 225,000 shares of common stock.
  • The transaction date for this grant was November 4, 2025.
  • The shares were acquired at a price of $0, indicating a grant rather than a purchase.
  • Following this transaction, William Keith Newton beneficially owns a total of 482,831 shares of common stock.
  • The restricted stock will vest in equal annual installments over a period of four years.

Sentiment

Score: 7

Explanation: The grant of restricted stock to the CEO is generally a positive event, as it aligns management's interests with shareholders and promotes long-term retention. While it represents a future compensation expense and potential minor dilution, the overall sentiment is positive for corporate governance and stability.

Positives

  • The grant of restricted stock aligns the Chief Executive Officer's long-term interests with those of the shareholders, incentivizing sustained company performance.
  • The four-year vesting schedule promotes executive retention and commitment to the company's strategic goals.

Negatives

  • The issuance of new shares, even restricted, can lead to minor dilution for existing shareholders over time as they vest.

Future Outlook

The restricted stock grant is structured to vest in equal annual installments over four years, indicating a long-term incentive for the CEO and a commitment to future performance.

Industry Context

The grant of restricted stock to a Chief Executive Officer is a common practice in publicly traded companies, serving as a key component of executive compensation packages designed to attract, retain, and motivate top talent while aligning their interests with long-term shareholder value.

Comparison to Industry Standards

  • Executive equity grants, particularly restricted stock with multi-year vesting, are a standard compensation tool across various industries, including healthcare services where Concentra operates.
  • The structure of vesting over four years is typical for long-term incentive plans, comparable to practices seen in companies like HCA Healthcare or Tenet Healthcare, which also utilize equity awards to incentivize their leadership.

Related Party Transactions

  • The grant of 225,000 shares of common stock to William Keith Newton, the Chief Executive Officer and a Director, constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

  • Shareholders: Potential for minor dilution over time as shares vest, but also increased alignment of CEO's interests with long-term shareholder value.
  • Employees: May signal stability in leadership and a commitment to long-term growth, potentially boosting morale.
  • Management: The CEO receives a significant long-term incentive, contingent on future performance and continued tenure.

Next Steps

  • The restricted stock will vest in equal annual installments over the next four years, subject to continued employment and other potential conditions.

Key Dates

DateDescription
11/04/2025Date of transaction for the grant of restricted stock.
11/06/2025Date of signature by Timothy F. Ryan, Attorney-in-Fact for William Keith Newton.

Keywords

Concentra Group Holdings Parent Inc., CON, William Keith Newton, Restricted Stock Grant, CEO Compensation, Insider Transaction, Equity Award, Executive Compensation, Form 4, Stock Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.